Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at sorafenib in skin schwannomas

Overview

Cancer types:

Non melanoma skin cancer, Skin cancer

Status:

Closed

Phase:

Other

Details

This trial is looking at how sorafenib (Nexavar) works in schwannomas of the skin.

Skin schwannomas are non cancerous () tumours that may develop on the skin of people who have a condition called type 2 (NF 2). NF 2 is a condition that is caused by changes in the in the body’s cells. People with NF 2 have an increased risk of developing certain types of tumours. Neurofibromatosis is difficult to treat and doctors are looking for new ways to manage it.

Recruitment start: 1 December 2011

Recruitment end: 1 March 2017

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Oliver Hanemann

Supported by

NIHR Clinical Research Network: Cancer

University Hospitals Plymouth NHS Trust

The Brain Tumour Charity

Last reviewed: 24 Jan 2019

CRUK internal database number: 8654

Help and support